ErinAlexisGillaspieMDMPH(She/Her)
Thoracic Surgery • Omaha, NEAdult General Thoracic Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology, Cardiovascular Surgery
Chief of Thoracic Surgery and Associate Professor of Thoracic Surgery at Creighton University Medical Center
Dr. Gillaspie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CUMC Bergan Mercy Hospital - CHI Health
7500 Mercy Rd
Omaha, NE 68124Phone+1 402-717-4900Fax+1 402-717-6064
Summary
- Dr. Erin Gillaspie is the Chief of Thoracic Surgery at CUMC Mercy Bergan in Omaha, NE. She completed her thoracic training at Mayo Clinic. She has been in practice 8 years. She speaks multiple languages including French and Spanish. She specializes in adult general thoracic surgery, thoracic oncology, esophageal surgery and robotic surgery.
Education & Training
Vanderbilt UniversityMPH, Public Health, 2016 - 2018
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Thoracic Surgery, 2013 - 2016- Bassett Medical CenterResidency, Surgery, 2009 - 2012
- Spartanburg Medical CenterInternship, Transitional Year, 2008 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2008
Certifications & Licensure
NE State Medical License 2023 - 2026
KY State Medical License 2021 - 2024
MS State Medical License 2022 - 2024
TN State Medical License 2016 - 2024
AL State Medical License 2020 - 2023
MN State Medical License 2013 - 2018
NY State Medical License 2011 - 2018- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- O.T. Clagett Traveling Scholarship Mayo Clinic
- AATS Graham Foundation Intuitive Surgical Robotics Fellowship AATS Graham Foundation, 2015
- Jeopardy Competition Finalist AATS AATS, 2015
- Join now to see all
Clinical Trials
- Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2020 Jul 17
- Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. Start of enrollment: 2020 Nov 30
Publications & Presentations
PubMed
- 5 citationsHiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosph...Juan M. Colazo, Joseph DeCorte, Erin A. Gillaspie, Andrew L. Folpe, Kathryn Dahir
Bone Reports. 2021-06-01 - 37 citationsSurvivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programm...James R. Patrinely, Arissa Young, Henry Quach, Grant R. Williams, Fei Ye
European Journal of Cancer. 2020-08-01 - 1211 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20
Press Mentions
Lung Cancer Screening Guidelines Were Recently Expanded. Here's Why They Could Be Life-SavingApril 5th, 2021- The Huff Project Donates $35K to Vanderbilt-Ingram Cancer CenterDecember 21st, 2020
Vanderbilt Surgeon Takes #NYerORCoverChallengeApril 13th, 2017- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
